Skip to main content
Log in

Subjective and behavioral effects of diazepam depend on its rate of onset

Psychopharmacology Aims and scope Submit manuscript

Abstract

This study addressed the assumption that rate of onset affects the euphorigenic effects of drugs. Drugs with rapid onset are commonly thought to be more euphorigenic than drugs with slower onset, but this idea has rarely been studied directly. Nine healthy male social drinkers, with no history of drug- or alcohol-related problems, participated in three sessions. On each session they received oral doses of placebo (PLAC), diazepam in a rapid onset condition (FAST), or diazepam in a slow onset condition (SLOW). In the FAST condition, they received a single 20 mg dose, whereas in the SLOW condition they received six 4 mg doses administered at 30-min intervals. Plasma levels of diazepam and desmethyldiazepam, subjective effects (including measures of euphoria), psychomotor performance and vital signs were monitored throughout each session. Although the FAST and SLOW conditions led to similar peak plasma levels of drug, the peak was attained earlier in the FAST condition (61 min versus 220 min). Subjects' scores on a measure of euphoria (MBG scale of the ARCI) were significantly higher in the FAST condition compared to the SLOW and PLAC conditions. Subjects exhibited significantly more behavioral signs of intoxication and greater psychomotor impairment in the FAST condition. Sedative effects of the drug were similar in magnitude, but the effects lasted slightly longer in the FAST condition. On several measures diazepam produced similar effects in the two conditions (e.g., ratings of strength of drug effect). These data provide limited support for the notion that a faster rate of onset of drug effects is associated with greater euphoria.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association, Washington, DC

    Google Scholar 

  • American Psychiatric Association (1990) Benzodiazepine dependence, toxicity, and abuse: a Task Force Report of the American Psychiatric Association. American Psychiatric Association, Washington, DC

    Google Scholar 

  • Bertilsson L, Henthorn TK, Sanz E, Tybring G, Säwe J, Villén T (1989) Importance of genetic factors in the regulation of diazepam metabolism: relationship toS-mephenytoin, but not debrisoquin, hydroxylation phenotype. Clin Pharmacol Ther 45:348–355

    Google Scholar 

  • Bliding A (1974) Effects of different rates of absorption of two benzodiazepines on subjective and objective parameters. Eur J Clin Pharmacol 7:201–211

    Google Scholar 

  • Busto U, Sellers EM (1986) Pharmacokinetic determinants of drug abuse and dependence. Clin Pharmacokinet 11:144–153

    Google Scholar 

  • Derogatis L (1983) SCL-90-R Manual-II. Clinical Psychometric Research, Towson, MD

    Google Scholar 

  • de Wit H (1991) Diazepam preference in males with and without an alcoholic first-degree relative. Alcohol Clin Exp Res 15:593–600

    Google Scholar 

  • de Wit H, Griffiths RR (1991) Methods of assessing the abuse liability of sedatives in humans. Drug Alcohol Depend 28:83–111

    Google Scholar 

  • de Wit H, Pierri J, Johanson CE (1989) Reinforcing and subjective effects of diazepam in non-drug-abusing volunteers. Pharmacol Biochem Behav 33:205–213

    Google Scholar 

  • de Wit H, Bodker B, Ambre J (1992) Rate of increase of plasma drug level influences subjective response in humans. Psychopharmacology 107:352–358

    Google Scholar 

  • Farré M, Camí J (1991) Pharmacokinetic considerations in abuse liability evaluation. Br J Addict 86:1601–1606

    Google Scholar 

  • Funderburk FR, Griffiths RR, McLeod DR, Bigelow GE, Mackenzie A, Liebson IA, Nemeth-Coslett R (1988) Relative abuse liability of lorazepam and diazepam: an evaluation in “recreational” drug users. Drug Alcohol Depend 22:215–222

    Google Scholar 

  • Ghoneim MD, Mewaldt SP (1990) Benzodiazepines and human memory: a review. Anesthesiology 72:926–938

    Google Scholar 

  • Greenblatt DJ, Sethy VH (1990) Benzodiazepine concentrations in brain directly reflect receptor occupancy: studies of diazepam, lorazepam, and oxazepam. Psychopharmacology 102:373–378

    Google Scholar 

  • Greenblatt DJ, Shader RI (1987) Pharmacokinetics of antianxiety agents. In: Meltzer HY (ed.) Psychopharmacology: The Third Generation of Progress. Raven, New York, pp 1377–1386

    Google Scholar 

  • Greenblatt DJ, Shader RI, Hermatz JS, Franke K, Koch-Weser J (1977) Absorption rate, blood concentrations, and early response to oral chlordiazepoxide. Am J Psychiatry 134:559–562

    Google Scholar 

  • Greenblatt DJ, Ochs HR, Lloyd BL (1980) Entry of diazepam and its major metabolite into cerebrospinal fluid. Psychopharmacology 70:89–93

    Google Scholar 

  • Greenblatt DJ, Arendt RM, Shader RI (1984) Pharmacodynamics of benzodiazepines after single oral doses: kinetic and physiochemical correlates. In: Hindmarch I, Ott H, Roth T (eds) Sleep, benzodiazepines and performance. Springer, Berlin Heidelberg New York, pp 92–97

    Google Scholar 

  • Greenblatt DJ, Harmatz JS, Friedman H, Locniskar A, Shader RI (1989) A large-sample study of diazepam pharmacokinetics. Ther Drug Monit 11:652–657

    Google Scholar 

  • Griffiths RR, Wolf B (1990) Relative abuse liability of different benzodiazepines in drug abusers. J Clin Psychopharmacol 10:237–243

    Google Scholar 

  • Griffiths RR, Bigelow GE, Liebson I, Kaliszak JE (1980) Drug preference in humans: double-blind choice comparison of pentobarbital, diazepam and placebo. J Pharmacol Exp Ther 215:649–661

    Google Scholar 

  • Griffiths RR, McLeod DR, Bigelow GE, Liebson IA, Roache JD, Nowowieski P (1984) Comparison of diazepam and oxazepam: preference, liking and extent of abuse. J Pharmacol Exp Ther 229:501–508

    Google Scholar 

  • Jaffe JH (1990) Drug addiction and drug abuse. In: Gilman AG, Rall TW, Nies AS, Taylor P (eds) Goodman and Gilman's The Pharmacological Basis of Therapeutics. Pergamon, New York, pp 522–573

    Google Scholar 

  • Johanson CE, Uhlenhuth EH (1980) Drug preference and mood in humans: diazepam. Psychopharmacology 71:269–273

    Google Scholar 

  • Jones DR, Hall SD, Jackson EK, Branch RA, Wilkinson GR (1988) Brain uptake of benzodiazepines: effects of lipophilicity and plasma protein binding. J Pharmacol Exp Ther 245:816–822

    Google Scholar 

  • Kaplan SA, Jack ML, Alexander K, Weinfeld RE (1973) Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administrations. J Pharm Sci 62:1789–1796

    Google Scholar 

  • Martin WR, Sloan JW, Sapira JD, Jasinski DR (1971) Physiologic, subjective and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine and methylphenidate in man. Clin Pharmacol Ther 12:245–258

    Google Scholar 

  • Mattila M (1988) Acute and subacute effects of diazepam on human performance: comparison of plain tablet and controlled release capsule. Pharmacol Toxicol 63:369–374

    Google Scholar 

  • McLeod DR, Hoehn-Saric R, Labib AS, Greenblatt DJ (1988) Six weeks of diazepam treatment in normal women. J Clin Psychopharmacol 8:83–99

    Google Scholar 

  • McNair D, Lorr M, Droppleman L (1971) Profile of mood states (manual). Educational and Industrial Testing Service, San Diego

    Google Scholar 

  • Parrott AC, Hindmarch I (1980) The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations — a review. Psychopharmacology 71:173–179

    Google Scholar 

  • Salonen M, Aantaa E, Aaltonen L, Hovi-Viander M, Kanto J (1986) A comparison of the soft gelatin capsule and the tablet form of temazepam. Acta Pharmacol Toxicol 58:49–54

    Google Scholar 

  • Tuomainen P (1989) A methodological comparison of two formulations of temazepam in pharmacokinetic and pharmacodynamic aspects. Pharmacol Toxicol 64:28–32

    Google Scholar 

  • Wechsler D (1958) The measure and appraisal of adult intelligence. Williams and Wilkins, Baltimore

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Wit, H., Dudish, S. & Ambre, J. Subjective and behavioral effects of diazepam depend on its rate of onset. Psychopharmacology 112, 324–330 (1993). https://doi.org/10.1007/BF02244928

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02244928

Key words

Navigation